// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























3340 Abstracts

Health Status Trajectories Among Outpatients with Heart Failure

Kelsey Flint - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Motivational Interviewing to Improve Self-care for Patients with Chronic Heart Failure: MITI-HF Randomized Controlled Trial

Ruth M. Masterson Creber - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Milrinone

Exercise Oscillatory Breathing is Associated With Ventricular Tachycardia, Atrial Fibrillation and Cardiomyopathy in Contemporary Patients Undergoing Metabolic Stress Testing

Antonio L. Perez - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Multicenter Experience of Technetium Pyrophosphate Scanning for Diagnosing TTR Cardiac Amyloid: A Revival in Nuclear Cardiology

Adam Castano - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Echocardiographic Predictors of Heart Failure in Hypertrophic Cardiomyopathy Secondary to Hypertension

Manminder Bhullar - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Methamphetamine

Cluster Analysis in Idiopathic Dilated Cardiomyopathy (IDC): Opportunity to Define Pathogenesis?

Monica P. Revelo - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Metabolomic Patterns in Heart Failure Patients Vary Across Demographic and Clinical Factors

David E. Lanfear - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Prognostic Role of Serum Chloride Levels in Acute Decompensated Heart Failure

Justin L. Grodin - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Angiotensin II

Elevated Hepatocyte Growth Factor is Associated With Worse Prognosis in Cardiac Amyloidosis

Eitan A. Friedman - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

MicroRNA-130a Regulation of Desmocollin2 in a Novel Model of Arrhythmogenic Cardiomyopathy

Stefan Mazurek - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

A Single, Non-Academic Experience with Use of ECPR

Peter Barrett - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Health Literacy as a Predictor of Adverse Outcomes after Implantation of Left Ventricular Assist Device

David Raymer - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

Methadone hydrochloride

Long Term Support of Acute, Refractory Cardiogenic Shock with an Extracorporeal, Continuous Flow Ventricular Assist Device: A Seven Year Experience

James M. Meza - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Impact of Cytomegalovirus on Survival After Heart Transplant: analysis of 20,000 Patients from the UNOS Registry Data

Guha Ashrith - Heart Failure Society of America (HFSA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

A NOVEL NON TETRAMERIC MUTANT OF TRANSTHYRETIN PROTEIN INVOLVED IN FAMILY CARDIAC AMYLOIDOSIS.

P.S. Ferreira - International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PDTM) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Magnetic Resonance is more sensitive than Echocardiography to detect Cardiomyopathy in Friedreichs Ataxia.

Alberto Martinez - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Genotypic and Phenotypic Presentation of TTR- FAP in Turkey

Hacer Durmus - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Peripheral Nervous System

Heart muscle disease

N/A

Takotsubo Cardiomyopathy Due To Status Epilepticus - An Underreported and Lethal Sequela

Imad Khan - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

Midazolam

A new muscle glycogen storage disease associated with Glycogenin-1 deficiency

Edoardo Malfatti - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Knowledge Regarding Oral Anticoagulation Therapy among Patients with Stroke and Those at High Risk of Thromboembolic Events

Rohit Bhatia - American Academy of Neurology (AAN) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Copyright © 2026. QuantiNova All rights reserved